Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTysabri risk causing headache for companies.AuthorsSheridan, CormacAbstractAdverse event could be present for all treatments for autoimmune conditions.SubjectsUNITED States; DRUG side effects; MULTIPLE sclerosis; MYELIN sheath diseases; PHARMACODYNAMICS; AUTOIMMUNE diseases; IMMUNOLOGIC diseases; PHARMACEUTICAL industry; PHARMACEUTICAL policyPublicationNature Reviews Drug Discovery, 2005, Vol 4, Issue 9, p703ISSN1474-1776Publication typeArticleDOI10.1038/nrd1837